September 24, 2026 · Gut · DOI: 10.1136/gutjnl-2025-336334

Metastatic pancreatic cancer: from human disease to preclinical modelling

Listen to this summary

The authors aim to elucidate the complexities of metastatic pancreatic ductal adenocarcinoma (PDAC), focusing on its clinical features, molecular heterogeneity, and the interactions between cancer cells and their microenvironments that complicate diagnosis and treatment. They review current preclinical models and highlight the limitations and future opportunities in precision oncology to improve clinical strategies against PDAC metastasis. Ultimately, the paper seeks to advance understanding and management of this lethal cancer type.

Jimin Min, Vasiliki Liaki, Peter Y Yu, Carmen Guerra, Anirban Maitra

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play